SARS-CoV-2 vaccination in patients with solid tumors or hematological malignancies: Is the pandemic over for fully vaccinated patients?
Author:
- 16 September 2021
- journal article
- editorial
- Published by Springer Nature in memo - Magazine of European Medical Oncology
- Vol. 14 (3) , 221-223
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older AdultsNew England Journal of Medicine, 2021
- Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 InfectionJAMA Oncology, 2021
- Mortality in hospitalized patients with cancer and coronavirus disease 2019: A systematic review and meta‐analysis of cohort studiesCancer, 2020
- A guide to vaccinology: from basic principles to new developmentsNature Reviews Immunology, 2020
- Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with CancerCell, 2020
- Chemotherapy and COVID-19 Outcomes in Patients With CancerJournal of Clinical Oncology, 2020
- COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort studyThe Lancet Oncology, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020
- Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trialBMJ, 2006
- Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trialThe Lancet, 2000